DMK Pharmaceuticals Corporation (DMKPQ)

DMK Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year Ending	Current	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Market Capitalization	0	25	90	45	43	106
Market Cap Growth	-78.34%	-71.81%	98.26%	5.25%	-59.43%	-27.57%
Enterprise Value	-6	25	68	43	38	90
PE Ratio	-	-0.96	-1.97	-0.92	-1.57	-2.73
PS Ratio	0.07	5.34	40.78	16.36	1.95	7.05
PB Ratio	-1.22	-31.42	3.48	12.99	1.31	2.28
P/FCF Ratio	-0.68	-0.96	-2.31	-2.13	-1.90	-2.94
P/OCF Ratio	-0.69	-0.98	-2.38	-2.17	-2.17	-3.26
EV/Sales Ratio	-0.04	5.18	30.57	15.45	1.74	5.95
EV/EBITDA Ratio	0.01	-0.98	-1.52	-0.91	-1.57	-2.48
EV/EBIT Ratio	0.01	-0.93	-1.47	-0.87	-1.40	-2.29
EV/FCF Ratio	0.02	-0.93	-1.73	-2.01	-1.69	-2.48
Debt / Equity Ratio	-0.01	-0.42	0.03	1.20	0.12	0.06
Debt / EBITDA Ratio	0.00	-0.01	-0.02	-0.09	-0.17	-0.07
Debt / FCF Ratio	-0.01	-0.01	-0.02	-0.20	-0.18	-0.07
Quick Ratio	0.49	0.19	2.60	0.35	1.14	1.77
Current Ratio	0.59	0.81	3.14	0.63	1.48	2.23
Asset Turnover	0.43	0.27	0.04	0.07	0.44	0.28
Interest Coverage	-	-	-6891.38	-10035.31	-222.14	-248.59
Return on Equity (ROE)	322.10%	-424.00%	-113.00%	-226.50%	-74.90%	-95.50%
Return on Assets (ROA)	-263.80%	-148.50%	-80.50%	-123.70%	-54.90%	-73.70%
Return on Capital (ROIC)	484.35%	5383.17%	-120.67%	-471.52%	-79.15%	-80.09%
Earnings Yield	-8464.66%	-104.28%	-50.88%	-108.71%	-63.73%	-36.66%
FCF Yield	-3604.33%	-104.68%	-43.31%	-47.00%	-52.71%	-34.01%
Buyback Yield / Dilution	-229.77%	-3.95%	-85.84%	-45.63%	-36.28%	-37.87%
Total Shareholder Return	-229.77%	-3.95%	-85.84%	-45.63%	-36.28%	-37.87%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).